Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy

Volume: 192, Pages: 11 - 21
Published: Apr 1, 2019
Abstract
Leishmaniasis is a neglected disease and drugs approved for its treatment often lead to abandonment, failure of therapy and even death. Photodynamic therapy (PDT) has been shown to be a promising, non-invasive and selective for a target region without requiring high-cost technology. Usually, it is employed a photosensitizing agent (PS) incorporated into nanoparticles (NP). Pluronics® P-123 and F-127 micelles are very interesting aqueous NP...
Paper Details
Title
Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy
Published Date
Apr 1, 2019
Volume
192
Pages
11 - 21
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.